WilmerHale Represents General Catalyst in Connection with $18.5 Billion Deal

• 8.5.2020

WilmerHale has advised General Catalyst, the largest shareholder of Livongo, in connection with the merger of Livongo and Teladoc Health. The merger, valued at $18.5 billion, brings together complementary leaders in virtual care and chronic condition management to create a global leader in consumer centered virtual care. The transaction is expected to close by the end of the fourth quarter of 2020, subject to customary closing conditions.

The WilmerHale team representing General Catalyst includes Jason Kropp, Hal Leibowitz, Andrew Bonnes and Molly Fox.

Read the full press release.